Ayumi E Pottenger

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ayumi E Pottenger, Debashish Roy, Selvi Srinivasan, Thomas E J Chavas, Vladmir Vlaskin, Duy-Khiet Ho, Vincent C Livingston, Mahdi Maktabi, Hsiuling Lin, Jing Zhang, Brandon S Pybus, Karl Kudyba, Alison Roth, Peter Senter, George Tyson, Hans E Huber, David Wesche, Rosemary Rochford, Paul A Burke, Patrick S Stayton
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure. Science advances 10 (16) (2024)
Ayumi E Pottenger, Debashish Roy, Selvi Srinivasan, Thomas E J Chavas, Vladmir Vlaskin, Duy-Khiet Ho, Vincent C Livingston, Mahdi Maktabi, Hsiuling Lin, Jing Zhang, Brandon S Pybus, Karl Kudyba, Alison Roth, Peter Senter, George Tyson, Hans E Huber, David Wesche, Rosemary Rochford, Paul A Burke, Patrick S Stayton
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure. Science advances 10 (16) (2024)
Ayumi E Pottenger, Debashish Roy, Selvi Srinivasan, Thomas E J Chavas, Vladmir Vlaskin, Duy-Khiet Ho, Vincent C Livingston, Mahdi Maktabi, Hsiuling Lin, Jing Zhang, Brandon S Pybus, Karl Kudyba, Alison Roth, Peter Senter, George Tyson, Hans E Huber, David Wesche, Rosemary Rochford, Paul A Burke, Patrick S Stayton
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure. Science advances 10 (16) (2024)
Ayumi E Pottenger, Debashish Roy, Selvi Srinivasan, Thomas E J Chavas, Vladmir Vlaskin, Duy-Khiet Ho, Vincent C Livingston, Mahdi Maktabi, Hsiuling Lin, Jing Zhang, Brandon S Pybus, Karl Kudyba, Alison Roth, Peter Senter, George Tyson, Hans E Huber, David Wesche, Rosemary Rochford, Paul A Burke, Patrick S Stayton
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure. Science advances 10 (16) (2024)